Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.
about
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Anticancer efficacy of the hyp ...... agonists against osteosarcoma.
@en
type
label
Anticancer efficacy of the hyp ...... agonists against osteosarcoma.
@en
prefLabel
Anticancer efficacy of the hyp ...... agonists against osteosarcoma.
@en
P2093
P2860
P50
P356
P1433
P1476
Anticancer efficacy of the hyp ...... agonists against osteosarcoma.
@en
P2093
Aneta Zysk
Christopher Difelice
David M Findlay
Irene Zinonos
Mark DeNichilo
Shelley Hay
Vasilios Liapis
Vladimir Ponomarev
P2860
P304
P356
10.1002/CAM4.1115
P407
P50
P577
2017-08-10T00:00:00Z